Hydroxyethyl Celluose, Glycerin Gel
NDC Package 69227-105-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Hydroxyethyl Celluose, Glycerin gel is a drug for further processing. This formulation utilizes a gel delivery system. Marketed by Klosterfrau Berlin Gmbh, this product is identified by NDC 69227-105.

Identification & Billing

NDC Package Code
69227-105-01
Package Description
5 mL in 1 SYRINGE, PLASTIC
Product Code
69227-105
11-Digit Billing Format
69227010501

Clinical Specifications

Proprietary Name
Hydroxyethyl Celluose, Glycerin
Non-Proprietary Name
Hydroxyethyl Celluose, Glycerin
Substance Name
Glycerin; Hydroxyethyl Cellulose (5500 Mpa.s At 2%)
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Klosterfrau Berlin Gmbh
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
10-16-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69227-105-01 identifies a specific commercial package of 5 ml in 1 syringe, plastic of Hydroxyethyl Celluose, Glycerin (UNFINISHED drug), drug for further processing labeled by Klosterfrau Berlin Gmbh. This gel is formulated for use and contains glycerin; hydroxyethyl cellulose (5500 mpa.s at 2%) as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Klosterfrau Berlin Gmbh on October 16, 2020. The current certification is valid through December 31, 2026.

How is this Klosterfrau Berlin Gmbh product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69227010501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69227-105-01
11-Digit CMS (5-4-2)
69227-0105-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.